drugset / Trial / NCT04581512
Study to Evaluate the Safety and Tolerability of EP0042
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A research study looking at a new treatment for patients with advanced cancer, to investigate different doses of the experimental study drug, EP0042, in order to determine a dose, which is safe, well-tolerated and likely to be effective in treating AML (acute myeloid leukaemia).
Timeline
- Start
- 2020-11-02
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | — | — |
| Subject | MOBINITINIB | Small molecule | 20 mg | Oral |
| Subject | MOBINITINIB | Small molecule | 50 mg | Oral |
| Subject | Venetoclax | Small molecule | — | — |